Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 25, 2021 at 06:53 am EDT
Share
Shenzhen Bioeasy Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 330.490 million compared to CNY 131.586 million a year ago. Operating income was CNY 182.792 million compared to CNY 45.560 million a year ago. Net income was CNY 163.308 million compared to CNY 39.214 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 0.11 a year ago.
Shenzhen Bioeasy Biotechnology Co Ltd is a China-based company mainly engaged in the research, development, production, sales and provision of food safety testing products and related services. The Companyâs main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.
SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD. 
